Heitzmann J G, Blomberg B, Cohn M
Mol Biol Med. 1986 Aug;3(4):339-50.
Fusion of WI-L2-729-HF2 human lymphoblastoid cells and human B-cell blasts provides a very efficient and rapid means of isolating stable B-cell hybridomas that secrete high levels of new human immunoglobulins. By titrating the plating density of fused cells into microwells immediately following fusion, it has been possible to obtain monoclonal hybrids. In this communication, proof of monoclonality is provided based on subcloning, karyotyping, and Southern blot analyses of lambda light chain immunoglobulin genes. The results reveal rearranged lambda genes in hybridoma subclones that produce both kappa (the WI-L2-729-HF2 isotype) and new lambda light chains. In contrast, the WI-L2-729-HF2 parental cell line and kappa-producing hybrids exhibit a germline configuration of lambda genes. The results provide evidence that stable, monoclonally derived hybridomas may be obtained upon initial plating of fused cells, without subsequent subcloning. The data further demonstrate the WI-L2-729-HF2 system to be ideal for rapidly generating, at very high frequency, clonal human B-cell hybridomas that stably secrete human monoclonal antibodies.
WI-L2-729-HF2人淋巴母细胞与人类B细胞母细胞的融合提供了一种非常高效且快速的方法,用于分离能够分泌高水平新型人类免疫球蛋白的稳定B细胞杂交瘤。通过在融合后立即将融合细胞的接种密度滴定到微孔板中,已能够获得单克隆杂交瘤。在本通讯中,基于λ轻链免疫球蛋白基因的亚克隆、核型分析和Southern印迹分析提供了单克隆性的证据。结果显示,在产生κ链(WI-L2-729-HF2的同种型)和新的λ轻链的杂交瘤亚克隆中存在重排的λ基因。相比之下,WI-L2-729-HF2亲本细胞系和产生κ链的杂交瘤表现出λ基因的种系构型。结果提供了证据,表明在融合细胞初次接种时即可获得稳定的、单克隆来源的杂交瘤,而无需后续亚克隆。数据进一步证明WI-L2-729-HF2系统非常适合以非常高的频率快速产生稳定分泌人单克隆抗体的克隆性人类B细胞杂交瘤。